Table 1.
All Treated Patients*
|
Intravenous recombinant tissue plasminogen activator#
|
Any Intra- arterial Therapy
|
Bridging Therapy&
|
Endovascular Therapy Alone^
|
||||||
---|---|---|---|---|---|---|---|---|---|---|
n = | % | n = | % | n = | % | n = | % | n = | % | |
Proportion over age 80 | 1182 | 31.4 | 1095 | 32.4 | 186 | 23 | 102 | 24 | 84 | 21.9 |
Sex (% female) | 1859 | 49.4 | 1699 | 50.4 | 419 | 52.1 | 219 | 51.8 | 200 | 52.4 |
Race/ethnicity | ||||||||||
Hispanic | 379 | 10.1 | 344 | 10.2 | 64 | 7.9 | 29 | 6.8 | 35 | 9.1 |
Non-Hispanic | 688 | 18.3 | 612 | 18.1 | 144 | 17.8 | 71 | 16.7 | 73 | 19.1 |
Non-Hispanic white | 2530 | 67.1 | 2269 | 67.2 | 559 | 69.2 | 301 | 70.8 | 258 | 67.4 |
Other | 171 | 4.5 | 153 | 4.5 | 41 | 5.1 | 24 | 5.6 | 17 | 4.4 |
Deaths | 431 | 12.1 | 359 | 12.2 | 145 | 18.5 | 76 | 18.3 | 69 | 18.8 |
Disposition (Not discharged home) | 2412 | 64 | 2119 | 62.7 | 628 | 77.7 | 340 | 80 | 288 | 75.2 |
NIHSS, median (IQR): 12 (6–18)
NIHSS, median (IQR): 16 (11–20)
NIHSS, median (IQR): 17 (13–20.5)
NIHSS, median (IQR): 15 (8–20)